Kazuki Nishida

Research

As a physician and biostatistician, I transform questions arising from clinical practice into testable studies through research design, biostatistics, epidemiology, and AI, with the aim of returning reliable evidence to clinical decision-making.

My research spans drug safety, emergency and critical care, and cerebrovascular and neurological medicine. Across these fields, I focus on identifying heterogeneity in treatment effects and risks, generating robust evidence from limited clinical data, and enabling privacy-preserving use of health data across institutions and national borders.

My research portfolio is shaped by both investigator-led programs and long-term collaborations with clinical specialists.

• Biostatistics
• Drug Safety
• Emergency & Critical Care
• Personalized Medicine
• Clinical Study Design
• Medical AI & Federated Learning

See research projects →

News

• 2026.07Original article on trauma outcome prediction using START criteria (first & corresponding author) published in Scientific Reports ↗
• 2026.06Original article (first author) on heterogeneity of clazosentan benefit after subarachnoid hemorrhage published in Neurocritical Care ↗
• 2026.06Original article (co-first author) on dynamic digital radiography and post-extubation respiratory deterioration published in PLOS ONE ↗
• 2026.05Original article (last & corresponding author) on sirolimus therapy and dyslipidemia in neonates and infants published in Paediatric Drugs ↗
• 2026.04Original article (first & corresponding author) on clindamycin and perioperative consciousness disturbance published in Clinical and Translational Science ↗

All news →

Selected Publications

Selected lead-author papers. See all 112 publications (incl. co-authorship) on researchmap.

1. A higher START red-criteria count at emergency department arrival is associated with increased 28-day mortality in the CRASH-2 trial.FirstCorrespondingKazuki Nishida, Hitoshi Mori, Keisuke Nishida, Isao Sakane, Marina Miyagawa, Ryo Emoto, Kota Matsui, Shigeyuki Matsui Scientific reports, 2026.
2. Heterogeneity of Clazosentan Benefit after Aneurysmal Subarachnoid Hemorrhage Demonstrated in an Externally Validated Causal Policy Tree.FirstKazuki Nishida, Basile Chrétien, Shinsuke Muraoka, Takashi Izumi, Masahiro Nishihori, Shunsaku Goto, Issei Takeuchi, Ryosuke Tashiro, Hiroyuki Sakata, Denis Vivien, Masaaki Mizuno, Hidenori Endo, et al Neurocritical care, 2026.
3. Sirolimus Therapy and Dyslipidemia in Neonates and Infants: A Retrospective Cohort and Pharmacovigilance Analysis.LastCorrespondingAkinobu Taniguchi, Basile Chrétien, Takashi Maeda, Kazuto Ueda, Ryosuke Miura, Ryuichi Tanaka, Toshihiko Suzuki, Yukako Muramatsu, Yoshiaki Sato, Kazuki Nishida Paediatric drugs, 2026.
4. Consciousness Disturbances Reported With Clindamycin Versus Cefazolin in Surgical Patients: A Global Pharmacovigilance Analysis Using VigiBase.FirstCorrespondingKazuki Nishida, Basile Chrétien, Hiroshi Morioka, Daigo Tamakoshi, Keita Hiraga, Tomoyuki Nakamura, Shigeyuki Matsui, Masahisa Katsuno, Yoshitaka Hara Clinical and translational science, 19(4), e70534, 2026.
5. Distance to Junction and Small Saphenous Vein Treatment Drive Risk of ≥Grade 2 Endothermal Heat-Induced Thrombosis in Multicenter Practice.Co-firstKiyoaki Niimi, Kazuki Nishida, Keisuke Hattori, Masato Tanaka, Koki Tabata, Hirofumi Morimae, Takuya Osawa, Changi Lee, Shuta Ikeda, Naohiro Akita, Masayuki Sugimoto, Hiroshi Banno Journal of vascular surgery. Venous and lymphatic disorders, 102488, 2026.
6. Association between dynamic digital radiography findings and post-extubation respiratory deterioration: A retrospective exploratory analysis of a prospectively collected ICU cohort.Co-firstSatoshi Komatsu, Kazuki Nishida, Yoshitaka Hara, Naohide Kuriyama, Tomoyuki Nakamura PloS one, 21(6), e0352029, 2026.

All lead-author papers →

Career

• 2026.04 – PresentProject Junior Associate Professor, Dept. of Clinical Biostatistics, Kyoto University Graduate School of Medicine
• 2026.04 – PresentVisiting Junior Associate Professor, Dept. of Anesthesiology & Critical Care Medicine, Fujita Health University
• 2026.04 – PresentJunior Associate Professor, Department of Biostatistics, Nagoya University Graduate School of Medicine
• 2025.04 – PresentAssistant Professor, Biostatistics, Kyoto University School of Public Health
• 2020.04 – 2025.03Assistant Professor, Center for Advanced Medicine & Clinical Research, Nagoya University Hospital
• 2014.04 – 2016.03Kainan Hospital, Aichi

Education

• 2016.04 – 2020.03PhD (Medicine), Biostatistics, Nagoya University Graduate School of Medicine
• 2008.04 – 2014.03MD, School of Medicine, Nagoya University

Grants

Competitive research funding (as principal or co-investigator).

• 2026–2029PIMachine-learning detection of heterogeneous safety signals using the international ADR database VigiBase（JSPS Grant-in-Aid for Early-Career Scientists）
• 2026–2029PIInternational sharing of medical data through privacy-preserving generative AI and federated learning（SECOM Science & Technology Foundation）
• 2026–2027PIApplying START triage to early trauma care: a secondary analysis of the CRASH-2 trial（Stryker Japan research grant）
• 2022–2025Co-IElucidating key mechanisms of sepsis-induced coagulopathy through big data and coagulation profiling（JSPS KAKENHI (C)）
• 2022–2025Co-IGene-mutation analysis of IPMN lesions and surrounding pancreas for early pancreatic-cancer diagnosis（JSPS KAKENHI (C)）
• 2021–2026Co-IComparing 33 °C vs 35 °C targeted temperature management on neurological outcomes after post-cardiac-arrest syndrome（JSPS KAKENHI (C)）
• 2021–2024Co-ITranslational development of an achondroplasia therapy via FGFR3 signal inhibition（AMED）
• 2020–2022PIUtility of P0.1 for timing of ventilator weaning: a diagnostic meta-analysis（JSPS Grant-in-Aid for Research Activity Start-up）

Books & Awards

• 2026.04Selected for the 2nd Japan–France Joint Travel Grant Program (Embassy of France in Japan / Kiyoko Goto–Paul Bourdarie Cancer Foundation) ↗
• 2024Modern Epidemiology (Japanese ed., Gakujutsu Tosho) — contributing translator
• 2023Encyclopedia of Clinical Trials (Asakura Shoten) — contributing author/translator
• 2016.04Tsuruma Award, FY2016 (Nagoya University Graduate School of Medicine)

Society: The Biometric Society of Japan

Qualifications

• Medical License (Japan)
• Certified Trial Statistician, The Biometric Society of Japan
• Japan Statistical Society Certificate (JSSC), Grade Pre-1
• Japan Statistical Society Certificate (JSSC), Grade 1 — Applied Statistics (Medical and Biological Sciences)
• EIKEN Test in Practical English Proficiency, Grade 1 (equivalent to CEFR C1)